Current status of PET/CT in the diagnosis and follow up of lymphomas
Lymphomas are a heterogeneous group of malignancies that have a distinct biological behavior according to the subtype and degree of differentiation. Adequate staging, which has a direct impact on prognosis, is essential to properly plan therapy. Structural cross-sectional imaging, such as computed t...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2011-01-01
|
| Series: | Revista Brasileira de Hematologia e Hemoterapia |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000200013 |
| _version_ | 1818516159593447424 |
|---|---|
| author | Carlos Alberto Buchpiguel |
| author_facet | Carlos Alberto Buchpiguel |
| author_sort | Carlos Alberto Buchpiguel |
| collection | DOAJ |
| description | Lymphomas are a heterogeneous group of malignancies that have a distinct biological behavior according to the subtype and degree of differentiation. Adequate staging, which has a direct impact on prognosis, is essential to properly plan therapy. Structural cross-sectional imaging, such as computed tomography, has been the standard imaging tool to stage and monitor patients with lymphoma. However, molecular imaging such as positron emission tomography has shown complementary diagnostic and prognostic values. This review discusses the current value of positron emission tomography imaging using 2-[fluorine-18]fluoro-2-deoxy-d-glucose in staging, restaging, monitoring and detecting relapse in Hodgkin's and non-Hodgkin lymphoma. |
| first_indexed | 2024-12-11T00:38:24Z |
| format | Article |
| id | doaj.art-23e43ed115004981802169dc1cc366b5 |
| institution | Directory Open Access Journal |
| issn | 1516-8484 1806-0870 |
| language | English |
| last_indexed | 2024-12-11T00:38:24Z |
| publishDate | 2011-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Revista Brasileira de Hematologia e Hemoterapia |
| spelling | doaj.art-23e43ed115004981802169dc1cc366b52022-12-22T01:27:01ZengElsevierRevista Brasileira de Hematologia e Hemoterapia1516-84841806-08702011-01-0133214014710.5581/1516-8484.20110035Current status of PET/CT in the diagnosis and follow up of lymphomasCarlos Alberto BuchpiguelLymphomas are a heterogeneous group of malignancies that have a distinct biological behavior according to the subtype and degree of differentiation. Adequate staging, which has a direct impact on prognosis, is essential to properly plan therapy. Structural cross-sectional imaging, such as computed tomography, has been the standard imaging tool to stage and monitor patients with lymphoma. However, molecular imaging such as positron emission tomography has shown complementary diagnostic and prognostic values. This review discusses the current value of positron emission tomography imaging using 2-[fluorine-18]fluoro-2-deoxy-d-glucose in staging, restaging, monitoring and detecting relapse in Hodgkin's and non-Hodgkin lymphoma.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000200013Lymph NodesLymphomaPositron-emission tomographyFluorodeoxyglucose F18Lymphoma, Hodgkin's diseaseLymphoma, non-Hodgkin |
| spellingShingle | Carlos Alberto Buchpiguel Current status of PET/CT in the diagnosis and follow up of lymphomas Revista Brasileira de Hematologia e Hemoterapia Lymph Nodes Lymphoma Positron-emission tomography Fluorodeoxyglucose F18 Lymphoma, Hodgkin's disease Lymphoma, non-Hodgkin |
| title | Current status of PET/CT in the diagnosis and follow up of lymphomas |
| title_full | Current status of PET/CT in the diagnosis and follow up of lymphomas |
| title_fullStr | Current status of PET/CT in the diagnosis and follow up of lymphomas |
| title_full_unstemmed | Current status of PET/CT in the diagnosis and follow up of lymphomas |
| title_short | Current status of PET/CT in the diagnosis and follow up of lymphomas |
| title_sort | current status of pet ct in the diagnosis and follow up of lymphomas |
| topic | Lymph Nodes Lymphoma Positron-emission tomography Fluorodeoxyglucose F18 Lymphoma, Hodgkin's disease Lymphoma, non-Hodgkin |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000200013 |
| work_keys_str_mv | AT carlosalbertobuchpiguel currentstatusofpetctinthediagnosisandfollowupoflymphomas |